Analyst Ratings for Zynerba Pharmaceuticals (ZYNE)

ZYNE Rating Summary

ZYNE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ZYNE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.25 (+128.3%) * Over Last 12-Mos
Rating Score: 6.4 / 10   Percentile Rank: 67%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/1/2020 Needham & Company Serge Belanger Downgrade Hold
(Buy)
N/A
(N/A)
3.37
(4.49)
33.23% Details
12/31/2019 Roth Capital
» Updated 6/30/2020
Scott R. Henry New Coverage Buy
(N/A)
8.50
(11.00)
5.64
(4.49)
-20.39% Details
Like ZYNE Ratings? Also take a look at VUZI, PUMP, GMED, YAYO

ZYNE Ratings News